Millennium Management’s BioCardia BCDA Stock Holding History

Millennium Management’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-769	Closed	-$24K	–	6361
2022 Q4	$24K	Sell	769 -667	-46%	-$19K	﹤0.01%	5996
2022 Q3	$42K	Sell	1,436 -451	-24%	-$11.7K	﹤0.01%	6235
2022 Q2	$42K	Buy	+1,887	New	+$45.2K	﹤0.01%	6254
2021 Q4	–	Sell	-668	Closed	-$31K	–	6786
2021 Q3	$31K	Buy	+668	New	+$32.8K	﹤0.01%	6633
2020 Q3	–	Sell	-1,151	Closed	-$41K	–	4441
2020 Q2	$41K	Sell	1,151 -994	-46%	-$53.8K	﹤0.01%	4060
2020 Q1	$104K	Sell	2,145 -2	-0.1%	-$124	﹤0.01%	3542
2019 Q4	$118K	Sell	2,147 -652	-23%	-$38.3K	﹤0.01%	3999
2019 Q3	$138K	Buy	+2,799	New	+$201K	﹤0.01%	3891

Other funds holding BCDA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Family Management New York $834M AUM 20.83% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management's BCDA Position: Q1 2023 in Review

Millennium Management sold out of BioCardia (BCDA) in Q1 2023, closing a stake of 769 shares — an estimated $24K sold.

Millennium Management first reported a position in BCDA in Q3 2019 and held it in 8 quarters. The position peaked at $138K in Q3 2019. 23 funds tracked by Wall St. Rank hold BCDA as of Q1 2023.

Millennium Management reported no remaining BioCardia position as of Q1 2023 after selling out during the quarter.
Millennium Management sold 769 BioCardia shares in Q1 2023, an estimated $24K.
Millennium Management first reported a position in BioCardia in Q3 2019 and held it in 8 quarters.
Millennium Management's BioCardia position peaked at $138K in Q3 2019.
23 funds tracked by Wall St. Rank held BioCardia as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.